☆ 4.4 Letter

Direct oral anticoagulants are effective and safe in the treatment of venous thromboembolism and atrial fibrillation in morbidly obese patients

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a meta-analysis

Mohamed Nabil Elshafei et al.

Summary: Direct oral anticoagulant agents are found to be non-inferior to warfarin in terms of efficacy and safety in the treatment of acute venous thromboembolism in morbidly obese patients, resolving the uncertainty surrounding the use of these agents in this patient population.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record data

Olivia S. Costa et al.

Summary: The prescription of rivaroxaban in obese VTE patients was associated with a significantly reduced risk of recurrent VTE compared to warfarin, without affecting major bleeding. These findings remained consistent across different BMI categories.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Meta-Analysis Comparing Direct Oral Anticoagulants Versus Warfarin in Morbidly Obese Patients With Atrial Fibrillation

Kazuhiko Kido et al.

AMERICAN JOURNAL OF CARDIOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Effectiveness and safety of rivaroxaban versus warfarin in obese nonvalvular atrial fibrillation patients: analysis of electronic health record data

Olivia S. Costa et al.

CURRENT MEDICAL RESEARCH AND OPINION (2020)

添加到收藏夹

Article Hematology

Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH

K. Martin et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)

添加到收藏夹

Direct oral anticoagulants are effective and safe in the treatment of venous thromboembolism and atrial fibrillation in morbidly obese patients

相关参考文献

Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a meta-analysis

Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record data

Meta-Analysis Comparing Direct Oral Anticoagulants Versus Warfarin in Morbidly Obese Patients With Atrial Fibrillation

Effectiveness and safety of rivaroxaban versus warfarin in obese nonvalvular atrial fibrillation patients: analysis of electronic health record data

Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH

导出引文

分享论文